Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004-03

Radiotherapy and Oncology

Volumn 103, Issue 1, 2012, Pages 57-62

  Toledano, Ivan ^a   Graff, Pierre ^b,c   Serre, Antoine ^d   Boisselier, Pierre ^d   Bensadoun, René Jean ^e   Ortholan, Cécile ^e   Pommier, Pascal ^f   Racadot, Séverine ^f   Calais, Gilles ^g   Alfonsi, Marc ^h   Favrel, Veronique ⁱ   Giraud, Philippe ^j   Lapeyre, Michel ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d CENTRE VAL D AURELLE   (France)

^e CENTRE ANTOINE LACASSAGNE   (France)

^f CENTRE LÉON BÉRARD   (France)

^g CHU BRETONNEAU   (France)

^h INSTITUT SAINTE CATHERINE   (France)

ⁱ CENTRE HOSPITALIER LYON SUD   (France)

^j INSTITUT CURIE   (France)

more..

Author keywords

Head and neck cancer; Intensity modulated radiotherapy; Late xerostomia; Parotid glands

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; NAVELBINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL (TOPIC); FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; NASOPHARYNX CANCER; NECK DISSECTION; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; RADIOTHERAPY, INTENSITY-MODULATED; XEROSTOMIA;

EID: 84859728169     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.12.010     Document Type: Article

References (28)

1. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582-9.
2. Braam P, Roesink J, Raaijmakers C, Busschers W, Terhaard C. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:975-80. (Pubitemid 44633513)
3. Graff P, Lapeyre M, Desandes E, et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1309-17. (Pubitemid 46467154)
4. Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001;61:275-80. (Pubitemid 33127232)
5. Martin E, Deville C, Bonnetain F, et al. Intensity-modulated radiation therapy in head and neck cancer: prescribed dose, clinical challenges and results. Radiother Oncol 2007;85:392-8. (Pubitemid 350213148)
6. Scott-Brown M, Miah A, Harrington K, Nutting C. Evidence-based review: quality of life following head and neck intensity-modulated radiotherapy. Radiother Oncol 2010;97:249-57.
7. Anaes. Evaluation de la radiothérapie conformationnelle avec modulation d'intensité. Rapport d'étape. Saint-Denis, www.anaes.fr (Agence nationale d'accréditation et d'évaluation en santé), mai 2003.
8. Gregoire V, Coche E, Cosnard G, Hamoir M, Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000;56:135-50. (Pubitemid 30601670)
9. Gregoire V, Levendag P, Ang K, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003;69:227-36. (Pubitemid 37485996)
10. Eisbruch A, Foote RL, O'Sullivan B, Beitler J, Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002;12:238-49. (Pubitemid 34755930)
11. Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002;53:1174-84. (Pubitemid 34787853)
12. Lapeyre M, Henrot P, Alfonsi M, et al. Proposition de sélection et délimitation des volumes cibles microscopiques péritumoraux dans les cancers de la cavité buccale et de l'oropharynx (aires ganglionnaires exclues). Cancer Radiother 2005;9:261-70. (Pubitemid 41115606)
13. Zefkili S, Tomsej M, Aletti P, et al. Recommendations for a head and neck IMRT quality assurance protocol. Cancer Radiother 2004;8:364-79. (Pubitemid 40023169)
14. Nutting C, Morden J, Harrington K, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36.
15. Caudell JP, Schaner E, Meredith R, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;73:410-5.
16. Meirovitz A, Murdoch-Kinch C, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006;66:445-53. (Pubitemid 44332730)
17. Yao M, Dornfeld K, Buatti J, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005;63:410-21. (Pubitemid 41317157)
18. Lee N, Xia P, Fishbein N, Akazawa P, Akazawa CM, Quivey J. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003;57:49-60. (Pubitemid 36959738)
19. Chao KS, Ozyigit G, Tran B, Cengiz M, Dempsey J, Low D. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;55:312-21. (Pubitemid 36069088)
20. Schoenfeld GO, Amdur RJ, Morris C, Li J, Hinerman R, Mendenhall W. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;71:377-85.
21. Bekelman J, Wolden S, Lee N. Head and neck target delineation among radiation oncology residents after a teaching intervention: a prospecitve blind pilot study. Int J Radiat Oncol Biol Phys 2009;73:416-23.
22. Eisbruch A, Kim H, Terrell J, Marsh L, Dawson L, Ship J. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704. (Pubitemid 32515326)
23. Eisbruch A, Kim HM, Ten Haken R, et al. Dose, volume and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87. (Pubitemid 29462636)
24. Li Y, Taylor J, Ten Haken R, Eisbruch A. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 2007;67:660-9. (Pubitemid 46215864)
25. Dijkema T, Raaijwakers C, Ten Haken R, et al. Parotid dose function after radiotherapy: the combined Michigan and Utrecht experience. Int J Radiat Oncol Biol Phys 2010;78:449-53.
26. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-16. (Pubitemid 32184597)
27. Murdoch-Kinch C, Kim H, Vineberg K, Ship J, Eisbruch A. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:373-82.
28. Eisbruch A. Reducing xerostomia by IMRT: what may, and may not, be achieved. J Clin Oncol 2007;25:4863-4.